News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Guided and aerial bombs struck residential areas and a hospital in eastern Ukraine, injuring dozens and escalating regional geopolitical risk.
  • HeartSciences filed its 2026 Form 10-K and proposed a merger with Fortitude Mining, shifting the company toward institutional cryptocurrency mining.
  • Azul's restructuring leaves a deeply discounted stock with asymmetric upside, but extreme volatility, residual leverage, and low liquidity make it high-risk.
  • ServiceNow's selloff on AI fears is pitched as a tactical long based on subscription growth, free cash flow, and early AI monetization.
  • Portillo's will report Q2 earnings Aug 5 after market close and host a 4:30 p.m. ET webcast.
  • Rapid Micro Biosystems will release Q2 results Aug 7 with an investor webcast.

Latest Articles

Global Mofy AI Limited Applies to Join Snowflake Partner Network to Advance Digital Content Data Ecosystem

Global Mofy AI Limited Applies to Join Snowflake Partner Network to Advance Digital Content Data Ecosystem

Global Mofy AI Limited (Nasdaq: GMM), a generative AI technology solutions provider specializing in virtual content production and 3D digital assets, announced its application to join the Snowflake Partner Network. This move aims to expand its global technology ecosystem and improve digital content data capabilities to support various sectors inclu…

Bogota Savings Bank and GSL Savings Bank to Merge

Bogota Savings Bank and GSL Savings Bank to Merge

Bogota Financial Corp., the holding company for Bogota Savings Bank, announced a merger agreement with GSL Savings Bank. The merger will increase Bogota Financial's consolidated assets to approximately $1 billion. Post-merger, GSL's CEO will join Bogota as Executive Vice President and COO. The transaction is expected to close in the second half of …

CECO Environmental Completes Acquisition of Thermon Group Holdings

CECO Environmental Completes Acquisition of Thermon Group Holdings

CECO Environmental Corp., a Nasdaq-listed company, announced the completion of its acquisition of Thermon Group Holdings, enhancing CECO's capabilities in industrial process heating and expanding its engineered solutions portfolio. The combined entity aims to drive long-term shareholder value and capitalize on key global industrial and environmenta…

T3 Defense Subsidiary Rimon Advances Delivery of Counter-UAS (C-UAS) Launcher Platforms for Elbit Systems' Active Defense Division

T3 Defense Subsidiary Rimon Advances Delivery of Counter-UAS (C-UAS) Launcher Platforms for Elbit Systems' Active Defense Division

T3 Defense Inc.'s wholly owned subsidiary Rimon agencies is progressing in manufacturing and delivering mobile counter-drone launcher platforms for Elbit Systems’ Active Defense division in Israel. These mobile systems integrate energy management, climate control, and stabilized sensors in trailers for rapid deployment and sustained operations with…

Oncolytics Biotech® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches

Oncolytics Biotech® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches

Oncolytics Biotech announced promising initial preclinical data showing enhanced anti-tumor activity when their immunotherapy pelareorep is combined with RAS pathway inhibitors in solid tumor models. These findings support further studies in pancreatic and colorectal cancers that harbor RAS mutations, aiming to improve immune activation and treatme…

Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT® Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting

Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT® Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting

Alpha Tau Medical announced positive overall survival and favorable safety results from a pooled analysis of three Phase I/II clinical studies of its Alpha DaRT therapy in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma. The treatment demonstrated median overall survival times notably exceeding historical data in secon…

Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus

Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus

Exagen Inc. announced publication of a systematic review confirming that its AVISE Lupus diagnostic test uniquely identifies 25% of lupus patients missed by conventional markers, demonstrating high accuracy and consistency across over 1,200 patients and 14 medical centers. This real-world evidence supports earlier diagnosis and intervention in Syst…

HUHUTECH International Group Provides Additional Details on €13.9 Million European Semiconductor Contract

HUHUTECH International Group Provides Additional Details on €13.9 Million European Semiconductor Contract

HUHUTECH International Group announced that its German subsidiary received seven purchase orders totaling approximately €13.9 million ($15 million) from a leading European advanced-node semiconductor wafer fabrication operator. Initial deposits have been received and revenue recognition is expected over fiscal years 2026 and 2027. The contract stre…

AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones

AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones

AIM ImmunoTech has announced early completion of patient enrollment in its Phase 2 DURIPANC trial testing Ampligen combined with AstraZeneca's Imfinzi for metastatic pancreatic cancer. This milestone accelerates the study timeline with primary endpoint evaluation planned for December 2026. The company highlights encouraging survival, safety, and qu…

Aluminium Climbs to Four-Year Peak as Middle East Supply Concerns Rise

Aluminium Climbs to Four-Year Peak as Middle East Supply Concerns Rise

Aluminium futures on the London Metal Exchange rose to their highest level in more than four years after escalations in the Middle East raised supply concerns. Benchmark aluminium traded at $3,690 a metric ton, up 0.6% at 0916 GMT on Friday, having earlier reached $3,707.50 - matching a May 26 level and the highest since March 2022. Regional disrup…

Swiss GDP Edges Up 0.4% as Manufacturing Rebounds

Swiss GDP Edges Up 0.4% as Manufacturing Rebounds

Switzerland's economy expanded by 0.4% in the first quarter of 2026, driven by a rebound in manufacturing output and an easing of U.S. tariff pressures. The quarterly gain accelerated from 0.2% in late 2025 and matched the country's long-term quarterly growth rate. While pharmaceuticals and chemicals contracted, stronger production in machinery, me…

LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors

LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors

LIXTE Biotechnology Holdings, Inc. announced a strategic transformation from a clinical-stage pharmaceutical company into an AI energy infrastructure equipment and services platform. The company will focus on addressing the growing power demands of AI and hyperscale data centers in North America. Stuart D. Porter, founder of Denham Capital, with ex…

Magyar Threatens Legal Route to Remove President After Refusal to Resign

Magyar Threatens Legal Route to Remove President After Refusal to Resign

Hungarian Prime Minister Peter Magyar announced he will initiate legal proceedings to remove President Tamas Sulyok if the president does not resign. Magyar, whose centre-right Tisza party swept to power in April, has repeatedly urged Sulyok - a Fidesz appointee elected by the previous parliament - to vacate the largely ceremonial presidency. Sulyo…

Outlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)

Outlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)

Outlook Therapeutics announced it has resubmitted its Biologics License Application (BLA) to the U.S. FDA for ONS-5010/LYTENAVA™, a treatment for neovascular age-related macular degeneration (nAMD). Following a successful appeal of a previous Complete Response Letter, the FDA confirmed substantial evidence of effectiveness for the drug and classifi…

Verisk Redefines U.S. Hurricane Risk Modeling with Reengineered Tropical Cyclone Model, Delivered on Its New Synergy Studio Platform

Verisk Redefines U.S. Hurricane Risk Modeling with Reengineered Tropical Cyclone Model, Delivered on Its New Synergy Studio Platform

Verisk Analytics introduced a reengineered U.S. Tropical Cyclone (hurricane) model delivered via its cloud-native Synergy Studio platform. The update incorporates advanced climate science, enhanced hazard and vulnerability modeling, and improved representation of storm surge, wind, and inland flooding risks. Designed to provide insurers, reinsurers…

Meta: From 'Zuckerberg Discount' to Premium - A Tactical Buy at $630

Meta: From 'Zuckerberg Discount' to Premium - A Tactical Buy at $630

Meta is trading below where its fundamentals and cash-generation suggest it should. Strong free cash flow ($48.25B), a lean balance sheet (debt/equity ~0.24), and accelerating AI-driven product initiatives create a pathway for the market to remove the so-called 'Zuckerberg discount' and award a premium multiple. This is a long-term trade idea with …